SYHA1402

N/A

Report date: 2022/01/17 12:14:22
NME

Base Information

Drug NameSYHA1402
Drug Alias NameSYHA1402SYHA-1402
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionAldose reductase inhibitors
TargetsAldose reductase
Therapy Area/IndicationsDiabetic peripheral neuropathyDiabetes MellitusDiabetic Cardiomyopathies +[6] 
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPhase 2 Clinical
Highest Status in ChinaPhase 2 Clinical
Originator CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
China Registration ClassClass 1 Chemical Drug in China

Develop Information

Active CompaniesCSPC Zhongqi Pharmaceutical Technology (Shijiazhuang) Co Ltd
Inactive CompaniesCspc Zhongqi Pharmaceutical Technology (Tianjin) Co Ltd
Active IndicationsDiabetic peripheral neuropathyDiabetic CardiomyopathiesPeripheral Nervous System Diseases
Inactive IndicationsDiabetes MellitusPolyneuropathiesDiabetic Neuropathies

Other Information

ATC CodeN/A
Related LinksN/A